Tikosyn and Renal failure acute - a phase IV clinical study of FDA data


Renal failure acute is found among people who take Tikosyn, especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Tikosyn and have Renal failure acute. It is created by eHealthMe based on reports of 11,127 people who have side effects when taking Tikosyn from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

11,127 people reported to have side effects when taking Tikosyn.
Among them, 27 people (0.24%) have Renal failure acute.

What is Tikosyn?

Tikosyn has active ingredients of dofetilide. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,498 Tikosyn users for its effectiveness, alternative drugs and more.

What is Renal failure acute?

Renal failure acute (rapid kidney dysfunction) is found to be associated with 3,073 drugs and 3,067 conditions by eHealthMe.

Number of Tikosyn and Renal failure acute reports submitted per year:

Could Tikosyn cause Renal failure acute?

Time on Tikosyn when people have Renal failure acute *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Renal failure acute when taking Tikosyn *:

  • female: 13.64 %
  • male: 86.36 %

Age of people who have Renal failure acute when taking Tikosyn *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 52.94 %
  • 50-59: 5.88 %
  • 60+: 41.18 %

Common drugs people take besides Tikosyn *:

  1. Lasix: 12 people, 44.44%
  2. Coreg: 11 people, 40.74%
  3. Spironolactone: 10 people, 37.04%
  4. Lisinopril: 10 people, 37.04%
  5. Ambien: 10 people, 37.04%
  6. Digoxin: 10 people, 37.04%
  7. Viagra: 9 people, 33.33%
  8. Byetta: 9 people, 33.33%
  9. Singulair: 9 people, 33.33%
  10. Synthroid: 9 people, 33.33%

Common side effects people have besides Renal failure acute *:

  1. Hypotension (abnormally low blood pressure): 10 people, 37.04%
  2. Exercise Tolerance Decreased: 9 people, 33.33%
  3. Aortic Valve Calcification: 9 people, 33.33%
  4. Supraventricular Extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle): 9 people, 33.33%
  5. Cholecystitis Acute (rapid infection of gallbladder): 9 people, 33.33%
  6. Cardiomyopathy (weakening of the heart muscle): 8 people, 29.63%
  7. Pulmonary Arterial Pressure Increased: 8 people, 29.63%
  8. Pulmonary Congestion (congestion in the lungs): 8 people, 29.63%
  9. Cardiac Failure: 8 people, 29.63%
  10. Leukocytosis (increased white blood cells): 8 people, 29.63%

Common conditions people have *:

  1. Ill-Defined Disorder: 2 people, 7.41%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 3.70%
  3. Pain: 1 person, 3.70%
  4. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 3.70%
  5. Cardiac Failure Congestive: 1 person, 3.70%
  6. Blood Glucose Increased: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tikosyn and have Renal failure acute?

Check whether Renal failure acute is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Renal failure acute and when was it recovered:

Expand to all the drugs that have ingredients of dofetilide:

Alternative drugs to, pros and cons of Tikosyn:

Common Tikosyn side effects:

Browse all side effects of Tikosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Renal failure acute treatments and more:

COVID vaccines that are related to Renal failure acute:

Common drugs associated with Renal failure acute:

All the drugs that are associated with Renal failure acute:

Common conditions associated with Renal failure acute:

All the conditions that are associated with Renal failure acute:

How the study uses the data?

The study uses data from the FDA. It is based on dofetilide (the active ingredients of Tikosyn) and Tikosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: